Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
1.855
-0.095 (-4.87%)
Sep 15, 2025, 3:47 PM EDT - Market open
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $200.96 million as of September 15, 2025. Its market cap has increased by 136.70% in one year.
Market Cap
200.96M
Enterprise Value
22.97M
1-Year Change
136.70%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has decreased from $214.50M to $200.96M, a decrease of -6.31%. That is a compound annual growth rate of -0.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 211.20M | 19.25% |
| Dec 31, 2024 | 177.10M | 138.04% |
| Dec 29, 2023 | 74.40M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.98% |
| Dec 31, 2021 | 890.20M | 220.56% |
| Dec 31, 2020 | 277.70M | 255.12% |
| Dec 31, 2019 | 78.20M | -74.15% |
| Dec 31, 2018 | 302.50M | -60.22% |
| Dec 29, 2017 | 760.40M | 30.72% |
| Dec 30, 2016 | 581.70M | 7.13% |
| Dec 31, 2015 | 543.00M | 153.15% |
| Oct 7, 2015 | 214.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |